Cargando…
IGF-1 Antibody Prolongs the Effective Duration Time of Botulinum Toxin in Decreasing Muscle Strength
Botulinum toxin type-A (Btx-A), a powerful therapeutic tool in various medical specialties, requires repeated injections to maintain its effect. Therefore, novel methods to prolong the effective duration time of Btx-A are highly needed. Rats were assigned to three major groups: control group (n = 30...
Autores principales: | Jin, Lingjing, Pan, Lizhen, Liu, Wuchao, Guo, Yan, Zheng, Yuguo, Guan, Qiang, Nie, Zhiyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3676772/ https://www.ncbi.nlm.nih.gov/pubmed/23698763 http://dx.doi.org/10.3390/ijms14059051 |
Ejemplares similares
-
The mechanism of botulinum A on Raynaud syndrome
por: Zhou, Yanwen, et al.
Publicado: (2018) -
Therapeutic efficacy and safety of botulinum toxin type A in trigeminal neuralgia: a systematic review
por: Hu, Yong, et al.
Publicado: (2013) -
Retroform Cervical Dystonia: Target Muscle Selection and Efficacy of Botulinum Toxin Injection
por: Hu, Yaowen, et al.
Publicado: (2022) -
Lantox—The Chinese Botulinum Toxin Drug—Complete English Bibliography and Comprehensive Formalised Literature Review
por: Dressler, Dirk, et al.
Publicado: (2021) -
Agrin Influences Botulinum Neurotoxin A-Induced Nerve Sprouting via miR-144-agrin-MuSK Signaling
por: Ma, Lin, et al.
Publicado: (2020)